Cristin-prosjekt-ID: 542128
Registrert av: REK Sist endret: 5. september 2021, 09:23 Sist endret av: REK

Cristin-prosjekt-ID: 542128
Registrert av: REK Sist endret: 5. september 2021, 09:23 Sist endret av: REK
Prosjekt

Effekten av vitamin B12-tilskudd hos Nepalske gravide på barnas vekst og utvikling

prosjektleder

Tor Arne Strand
ved Universitetet i Bergen

prosjekteier / koordinerende forskningsansvarlig enhet

  • Universitetet i Bergen

Godkjenninger

  • Regionale komitéer for medisinsk og helsefaglig forskningsetikk (REK) - 2016/1620

Kategorier

Prosjektkategori

  • Bidragsprosjekt

Helseprosjekttype

Legemiddelstudium - Utprøvingsfase 4

Tidsramme

Aktivt
Start: 1. november 2016 Slutt: 1. mars 2025

Beskrivelse Beskrivelse

Tittel

Effekten av vitamin B12-tilskudd hos Nepalske gravide på barnas vekst og utvikling

Populærvitenskapelig sammendrag

Vitamin B12 is crucial for cell division and necessary for brain development. Pregnant mothers in low income countries such as Nepal often lack vitamin B12. The infant depend on the mother for vitamin B12 early in life. Poor vitamin B12 status in infancy is linked to poor growth and neurodevelopment. We will enroll 600 pregnant women residing in Bhaktapur, Nepal to a randomized placebo controlled clinical trial. The women will be enrolled no later than in week 15 of pregnancy and receive a daily dose of 50 µg of vitamin B12/placebo until 6 months after birth. We will visit the women weekely to record compliance and morbidity. At birth, gestational age and birth weight will be registered and we wil record infant growth monthly until 12 month. Neurodevelopment will be measured at 6 and 12 months of age. The result from the study may support new dietary guidelines for South Asian pregnant women that can lead to improved growt and development in children.

Tittel

Effekten av vitamin B12-tilskudd hos Nepalske gravide på barnas vekst og utvikling

Populærvitenskapelig sammendrag

Vitamin B12 is crucial for cell division and necessary for brain development. Pregnant mothers in low income countries such as Nepal often lack vitamin B12. The infant depend on the mother for vitamin B12 early in life. Poor vitamin B12 status in infancy is linked to poor growth and neurodevelopment. We will enroll 600 pregnant women residing in Bhaktapur, Nepal to a randomized placebo controlled clinical trial. The women will be enrolled no later than in week 15 of pregnancy and receive a daily dose of 50 µg of vitamin B12/placebo until 6 months after birth. We will visit the women weekely to record compliance and morbidity. At birth, gestational age and birth weight will be registered and we wil record infant growth monthly until 12 month. Neurodevelopment will be measured at 6 and 12 months of age. The result from the study may support new dietary guidelines for South Asian pregnant women that can lead to improved growt and development in children.

prosjektdeltakere

prosjektleder

Tor Arne Strand

  • Tilknyttet:
    Prosjektleder
    ved Universitetet i Bergen
1 - 1 av 1